Revisiting emergency department use of buprenorphine as a primary analgesic in nonopioid use disorder patients post-X-waiver
- PMID: 37119058
- DOI: 10.1111/acem.14749
Revisiting emergency department use of buprenorphine as a primary analgesic in nonopioid use disorder patients post-X-waiver
Keywords: DEA; OUD; SAMHSA; health policy; opiate.
References
REFERENCES
-
- Centers for Disease Control and Prevention. Opioids: Understanding the Opioid Overdose Epidemic. 2022. Accessed February 26, 2023 https://www.cdc.gov/opioids/basics/epidemic.html
-
- Wei Y-JJ, Chen C, Fillingim R, Schmidt SO, Winterstein AG. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: a cross-sectional study. PLoS Med. 2019;16(11):e1002941.
-
- Sporer KA. Buprenorphine: a primer for emergency physicians. Ann Emerg Med. 2004;43(5):580-584.
-
- Berk J. To Help Providers Fight The Opioid Epidemic, “X The X Waiver”. Health Affairs; 2019. Accessed February 26, 2023. doi: 10.1377/forefront.20190301.79453/full/
-
- Mauro PM, Gutkind S, Annunziato EM, Samples H. Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019. JAMA Netw Open. 2022;5(3):e223821.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical